StockData
West Pharmaceutical Services Inc logo

West Pharmaceutical Services Inc (WST) income statement

WSTNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 20/3025% above fair value
$390.30−6.39 (-1.61%)

Close on Nov 20, 2026Market cap $27.19BP/E 43.8Yield 0.22%

West Pharmaceutical Services Inc financial ratios

See a number that looks wrong?